Junzhi
JUNZHI Biomedical is a Taiwanese biotech team dedicated to preventive healthcare. They provide convenient and precise testing solutions, focusing on early detection of cancers, especially gastrointestinal cancers, through advanced SAA protein testing technology. Their mission is to promote health and early diagnosis, leveraging cutting-edge research and international collaborations.
Industries
Services
SAA protein-based blood screening service for gastrointestinal cancers
Clinical laboratory service that analyzes serum SAA isoform patterns from a single blood draw to assess risk for gastric and colorectal cancer. Workflow includes magnetic nanoparticle enrichment, MALDI-TOF MS profiling, AI-based data analysis, and a diagnostic report provided to the ordering clinician or patient.
Clinical laboratory testing and sample processing services
Laboratory services including nanoparticle-based sample purification, mass spectrometry analysis, data processing, and generation of clinical reports for biomarker screening assays.
Technology collaboration and licensing support
Collaborative R&D and licensing arrangements with academic partners and industry to develop, validate, and internationalize nanoparticle-assisted mass-spectrometry diagnostic platforms.
SAA protein-based blood screening service for gastrointestinal cancers
Clinical laboratory service that analyzes serum SAA isoform patterns from a single blood draw to assess risk for gastric and colorectal cancer. Workflow includes magnetic nanoparticle enrichment, MALDI-TOF MS profiling, AI-based data analysis, and a diagnostic report provided to the ordering clinician or patient.
Clinical laboratory testing and sample processing services
Laboratory services including nanoparticle-based sample purification, mass spectrometry analysis, data processing, and generation of clinical reports for biomarker screening assays.
Technology collaboration and licensing support
Collaborative R&D and licensing arrangements with academic partners and industry to develop, validate, and internationalize nanoparticle-assisted mass-spectrometry diagnostic platforms.
Expertise Areas
- Biomarker discovery and validation
- Proteomics and mass spectrometry
- Nanoparticle-based sample enrichment
- AI-driven diagnostic algorithm development
Key Technologies
- MALDI-TOF mass spectrometry
- Magnetic nanoparticle immunoaffinity enrichment
- Antibody-conjugated nanoprobes
- Isoform-resolved proteomics